Waldencast plc
WALD
Positions held
Your positionsWALD isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $111.87M | Enterprise value | $254.89M | Trailing P/E | — | Forward P/E | -1.10 |
| PEG | — | Price / book | 0.23 | Beta | 0.01 | Dividend yield | 0.00% |
| Revenue growth | -80.3% | Earnings growth | — | Gross margin | 65.8% | Operating margin | -1.6% |
| Profit margin | -70.2% | ROE | -62.7% | ROA | -7.5% | Debt / equity | 0.38 |
| Current ratio | 4.80 | Free cash flow | -$237.69M | Analyst recommendation | buy | Mean target | $2.05 |
| 52w high | $3.22 | 52w low | $0.72 |
Quarterly
No data yet.
Yearly (6y)
| 2025 | 2024 | 2023 | 2021 | |
|---|---|---|---|---|
| Revenue | $272M | $274M | $218M | $142M |
| Op margin | -23.9% | -19.6% | -37.6% | -1.1% |
| Net income | -$230M | -$42.4M | -$90.0M | -$19.6M |
| Gross margin | 67.3% | 70.0% | 64.9% | 61.4% |
| Gross profit | $183M | $192M | $142M | $87.4M |
| Operating income | -$65.0M | -$53.6M | -$81.9M | -$1.6M |
Headline risk — review
• [CRITICAL · listing] Waldencast Files to Delist Shares, Warrants From Nasdaq
• [CRITICAL · listing] Waldencast plc Announces Intention to Voluntarily Delist from Nasdaq and Deregister its Securities under the Exchange Ac
• [CRITICAL · listing] Waldencast plc Files Form 25 to Voluntary Delist from Nasdaq and Deregister its Securities under the Exchange Act
News
2026-09-28 · Waldencast plc Announces First Half 2026 Financial Results
2026-09-24 · Waldencast Files to Delist Shares, Warrants From Nasdaq
2026-09-24 · Waldencast plc Files Form 25 to Voluntary Delist from Nasdaq and Deregister its Securities under the Exchange Act
2026-09-14 · Sector Update: Consumer Stocks Mixed Pre-Bell Monday
2026-09-14 · Sector Update: Consumer
2026-09-14 · Top Premarket Decliners
2026-09-14 · Waldencast Plans Voluntary Nasdaq Delisting; Shares Down Pre-Bell
2026-07-30 · Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint
Price (daily)
Full chart · RSI · MACD · patterns